Boston Scientific Corp (FRA:BSX)
€ 67.5 -1 (-1.46%) Market Cap: 99.39 Bil Enterprise Value: 107.44 Bil PE Ratio: 61.18 PB Ratio: 5.37 GF Score: 84/100

Q4 2020 Boston Scientific Corp Earnings Call Transcript

Feb 03, 2021 / 01:00PM GMT
Release Date Price: €30.84 (+0.51%)
Operator

Good morning, and welcome to the Boston Scientific Fourth Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Susan Lisa, Vice President, Investor Relations. Please go ahead.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thank you, Andrew. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer. We issued a press release earlier this morning announcing our Q4 2020 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials & Filings.

The duration of this morning's call will be approximately 1 hour. Mike will focus his comments on Q4 performance, inclusive of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot